Victor Moreno, MD, PhD, medical oncologist, director, Clinical Research, START Madrid-Fundación Jimenez Diaz (FJD), discusses insights into the pharmacodynamic data for CLN-619, a novel humanized IgG1 antibody designed to bind to MICA and MICB, in patients with advanced solid tumors. Findings were presented by Moreno and colleagues during the 2024 SITC Annual Meeting.
Of Interest
Moffitt Study Shows Immune Structures in Melanoma Could Help Predict Patient Survival
TAMPA, Fla. — A new study has found that certain immune structures may be linked to better survival in patients with melanoma, the deadliest form of skin cancer. The study, led by researchers at Moffitt Cancer Center in collaboration with investigators at UPMC Hillman Cancer Center, was published in the Journal for ImmunoTherapy of Cancer.
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma
For patients with melanoma, treatment with CAR-T cell therapy may come along with pros and cons to consider.
Remote Telemedicine Tool Found Highly Accurate in Diagnosing Melanoma
Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a new study shows.